BCI has completed a capital increase with public and private investors
BCI has completed a US$600 million capital increase with investment funds, pension funds and foreign investors.
BCI is the third largest privately owned bank in Chile, with 15.4% of loan market share. BCI is a commercial bank operating in every loan and client segment. The bank is controlled by the Yarur Family and, according to SBIF, has 304 branches in Chile. In September 2015, the bank obtained the FED’s approval to finalize the purchase of CNB Florida, an operation that began at the end of the year. In 2017, BCI announced the acquisition of Totalbank and WSF.
Oaklins’ team in Chile acted as advisor in BCI’s capital increase through an auction and preferential option period.
![](/files/styles/hero_image/public/FINTECH%20deal%201_0.jpg)
![](/api/deal-party-images/104898/deal-parties.png)
Contáctese con el equipo de la transacción
Transacciones relacionadas
True Securitizadora has been acquired by Opea
The private shareholders of True Securitizadora have sold the company to Opea Securitizadora. The acquisition is part of Opea’s strategy to expand its portfolio of services and products, and reinforce its operations in securitization.
Aprenda másFRP Advisory Group plc has finalized a successful secondary placing
FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.
Aprenda másTabula Investment Management has been acquired by Janus Henderson Group plc
Tabula Investment Management has been sold to Janus Henderson Group plc. The deal builds on Janus Henderson’s extremely successful active fixed income ETF proposition in the US, where it is the fourth largest provider of active fixed income ETFs by assets under management. The transaction is expected to complete in the second quarter of 2024, subject to usual closing conditions, including regulatory approvals.
Aprenda más